ESMO: Positive Results Buoy Chinese Oncology Developers' Global Hopes

 
• By Dexter Jie Yan

Promising new clinical results presented at ESMO are likely to help several Chinese firms gain traction to take their new drug candidates into global markets, including the US.

Encouraging trial results help buoy Chinese drug maker's hopes for entry into the US market.
Encouraging trial results buoy Chinese companies' US entry hopes • Source: Shutterstock

More from China

More from Focus On Asia